Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPT-821 and Vaccine Therapy in Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT00857545Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jul 2010
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NSC 748933 in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Jul 2010; status: completed.
02
Drugs
NSC 748933
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00857545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00857545.